GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other undervalued ... Some of the most common and pure-play industry groups considered defensive include ...

GlaxoSmithKline (GSK) has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business with Pfizer, according to ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point ... Read ...

Tata AIG has appointed Shekhar Saurabh as its Head of Marketing. The news has been shared by Saurabh in a LinkedIn update.

Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh ...

Before this role, Saurabh worked at Godrej Consumer Products, where he most recently served as the category head of marketing for home care.

GSK) is a British global pharmaceutical and healthcare company that develops and markets a wide range of medicines, vaccines, and consumer health products. The company is a leader in immunology ...